CP-690,550 eye drops

tofacitinib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-690,550 eye drops, covering 2013-05-07 to 2013-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease [Phase 2]